PathogenX Names Chuck Berkeley Chairman of the Board

CARMEL, Calif.--()--Carmel-based medical device company PathogenX has named Chuck Berkeley Chairman of its Board of Directors. Berkeley, a founder of PathogenX, will continue to also serve in his current role as CEO of the company.

Berkeley has spent the last 10 of his 20-year sales and management career in the medical device and healthcare technology sector. Prior to his current role as co-founder and CEO for Cypress Holdings Group, Inc, the parent company of PathogenX, Berkeley founded medical device distributorship Grey Medical, LLC in 2015.

Outside of the medical device innovation world, Berkeley has also made a name for himself as a world-class athlete. He competed in the 2010 Olympic Games as a bobsledder and has won multiple World Cup and Americas Cup gold and silver medals in the two-man and four-man bobsled.

His passion for game-changing solutions to wide-spread medical challenges led him to PathogenX. The company develops, manufactures, and distributes the PX2, a proprietary technology designed to dramatically simplify the process of medical waste disposal. The unique, double-batch, on-site sterilization device, about the size of a laser printer, safely and efficiently renders regulated medical waste (such as sharps) completely sterile, unrecognizable and non-reusable in compliance with all federal EPA, CDC and OSHA standards and guidelines. Each PX2 device is capable of processing up to 10 gallons of medical waste per day.

The PX2 system destroys all microbes, including COVID-19, while melting the biomedical waste so that a resulting “brick” of harmless, sterilized material can be easily disposed of in the standard trash. In the wake of the pandemic and the exponential growth of sharps for vaccines and tests, Berkeley and PathogenX are, with PX2, responding to a critical need.

PX2 technology is now available throughout the United States and Canada for use by hospitals and health facilities; research centers and laboratories; mortuary and autopsy centers; animal research and testing laboratories; veterinary facilities; blood banks; nursing homes for the elderly; and other health-related venues where blood is drawn.

Disposing of medical waste on-site with the PX2 is also considerably less expensive than haul-and-treat services and the company offers its customers financing and lease-to-own options so that the device pays for itself.

The mission of PathogenX, Inc. is to reimagine and change the way nearly one million U.S. low-volume generators manage their infectious waste by offering an economic, efficient and environmentally safe solution, which also serves to eliminate liability. Learn more at pathogenx.com.

Contacts

Media Contact: Paul Williams, 310-569-0023, paul@medialinecommunications.com

 

Social Media Profiles

Contacts

Media Contact: Paul Williams, 310-569-0023, paul@medialinecommunications.com